Procter & Gamble Health Limited has formally notified the Bombay Stock Exchange (BSE) and National Stock Exchange of India Limited (NSE) regarding the re-appointment of Mr. S. Madhavan as an Independent Director of the company.
The re-appointment is for a period of five years, effective from November 15, 2026. This appointment was subject to shareholder approval, which was obtained at the company's 59th Annual General Meeting (AGM) held on September 3, 2026.
The disclosure references the company's previous communication dated May 26, 2026, which initially proposed this re-appointment. The current filing serves as formal notification to the exchanges that the shareholder approval requirement has been fulfilled.
The document was signed by Flavia Peter Machado, Authorised Signatory for Procter & Gamble Health Limited, on September 4, 2026 at 17:07:01 IST.
Financial Impact
No financial impact disclosed in the filing. The disclosure pertains solely to corporate governance and board composition matters.